Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
ABLYNX, Adagio, adulteration, affinity, aid, Alpha, AMP, anesthesiologist, Annex, apportioned, assessor, asthma, Biden, Biophysical, branch, breakthrough, bride, broader, built, burdensome, CA, CFR, clarify, CMDh, Corrupt, COVAX, Dear, debate, degeneration, Delta, der, destroyed, detention, discourage, dispensed, dispensing, endorsed, endorsement, entail, ERP, ETASU, expedite, facilitate, Fast, FCA, FCPA, FDASIA, FDCA, ffentlichen, Gavi, GmbH, Green, immaterial, implanted, increasingly, indefinite, inexperience, infused, inhalation, inhaled, instilled, interactive, IP, IRR, irreversible, Jay, juncture, kickback, landscape, largest, lengthen, lessen, MAcc, macular, Max, MDRP, misbranding, misleading, MPG, MPI, Mutual, NanoAb, Nanobody, nanosized, neutralization, neutralize, obstructing, Omicron, Ontario, outpatient, overpayment, panel, parent, PDMA, peer, pervasive, pharmacology, pharmacy, PHSA, Planck, postmarketing, potent, poverty, practitioner, predominant, prerequisite, progressive, psoriatic, pure, qui, rare, reapplied, reconsider, recordkeeping, recurrent, redacted, remote, renegotiation, Rescue, resubmission, route, signal, Society, sponsorship, stealing, step, Stiftung, subpopulation, sue, surrogate, survey, surveyed, switched, tam, tone, transformation, transmissible, Trump, UMG, unannounced, unmet, usage, variant, Veteran, VHH, Vir, VoC, Waterloo, Wissenschaften, withdrawn, wrong, zur
Removed:
abandoned, achieved, affiliate, alleged, allotted, alumni, arrange, Assignee, assist, assume, ATM, Australia, bad, batch, Ben, Biopharmacy, blocked, bond, Boston, Brazil, cancel, cellular, cent, certificate, charged, circumvented, clearing, cohort, commented, compensate, conferred, confirmed, consequential, consolidate, contact, contacting, convert, coordinate, Coordinator, copying, council, county, creative, DC, deduct, deficiency, depository, detected, device, direction, directive, discretionary, division, domain, DTC, dual, dynamic, EC, element, England, escalation, ESOP, essence, evidencing, Fax, feasible, finally, forbid, formed, formulae, fraction, fractional, freedom, genuine, Goshen, grantee, Groningen, Harvard, headed, Hong, humoral, immune, immunogenicity, importation, improved, incorporate, industrial, instituting, intramuscularly, invent, inventory, Ireland, Japan, Kingdom, Kong, Korea, lawsuit, licensee, liquidate, location, London, mailing, merge, Mexico, mild, MINE, motivate, MULTIEPITOPE, MULTIMERIC, multinational, nearest, negotiable, noted, parliament, partially, partly, PCT, preceded, procuring, Prov, punitive, QP, question, rationally, reaction, Recapitalize, Reclassify, redemption, reflect, releasing, remediate, reorganize, replicate, representative, resign, restatement, round, Russia, scheduled, season, sentence, ship, short, signature, solicit, South, Spain, split, standalone, stockpile, subscribe, Suisse, summa, summarize, supplied, Switzerland, territory, therefrom, TIMETABLE, Tokyo, told, trained, transferability, trend, unanimously, uncertificated, unregistered, UNRESOLVED, vast, Weizman, Zealand, Ziona
Filing tables
Filing exhibits
- 20-F Annual report (foreign)
- 4.4 Employment Agreement Dated January 20, 2021, Between Biondvax Pharmaceuticals LTD. and MR. Amir Reichman
- 4.16 License Agreement, Dated December 11, 2021, Between Biondvax Pharmaceuticals LTD. and Max-planck-innovation GMBH
- 4.17 Accompanying Research Collaboration Agreement, Dated December 11, 2021
- 4.18 Research Collaboration Agreement, Dated March 23, 2022, Between Biondvax Pharmaceuticals LTD., Max-planck-gesellschaft Zur Forderung Der Wissenschaften E.v and Georg-august-universitat Gottingen Stiftung Offentlichen Rechts Universitatsmedizin Gottingen
- 4.19 Form of License Agreement Between Biondvax Pharmaceuticals LTD., Max-planck-gesellschaft Zur Forderung Der Wissenschaften E.v and Georg-august-universitat Gottingen Stiftung Offentlichen Rechts Universitatsmedizin Gottingen
- 10 Consent of Kost Forer Gabbay & Kasierer, Certified Public Accountant (Isr.), a Member of Ernst & Young Global, Independent Registered Public Accounting Firm for the Registrant.
- 12.1 Certification
- 12.2 Certification
- 13.1 Certification
- 13.2 Certification
- Download Excel data file
- View Excel data file
Associated SCNI transcripts
SCNI similar filings
Filing view
External links
Exhibit 13.1
CERTIFICATION BY CHIEF EXECUTIVE OFFICER PURSUAN TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of BiondVax Pharmaceuticals Ltd. (the “Company”) on Form 20-F for the period ended December 31, 2021 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned officer of the Company certifies, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that to such officer's knowledge:
(1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
(2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Dated: March 28, 2022 | |
/s/ Amir Reichman | |
Amir Reichman | |
Chief Executive Officer |